Metraipolis › archive › dc_3a8fa643dbf9

Real-time electronic drug monitoring: experiences from a multinational phase 3 clinical trial to prevent multidrug-resistant TB — Europe PMC PMID:42125014

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125014
DOI
10.5588/ijtldopen.25.0702
License (as archived)
solo-consultazione
Archived
2026-11-02T12:12:32.770Z
SHA-256 of the archived text
625a5202e5a59e39e1dcd7a70c74d989b4d2ec174f2357cff5fce7b93dbafef4
Stable URL of this page
https://metraipolis.com/documento/dc_3a8fa643dbf9

How to cite

Real-time electronic drug monitoring: experiences from a multinational phase 3 clinical trial to prevent multidrug-resistant TB — Europe PMC PMID:42125014 — Europe PMC (en), https://europepmc.org/article/MED/42125014 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3a8fa643dbf9 (Metraipolis archive dc_3a8fa643dbf9, sha256 625a5202e5a59e39e1dcd7a70c74d989b4d2ec174f2357cff5fce7b93dbafef4)
BibTeX
@misc{dc3a8fa643dbf9,
  title = {Real-time electronic drug monitoring: experiences from a multinational phase 3 clinical trial to prevent multidrug-resistant TB — Europe PMC PMID:42125014},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125014},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3a8fa643dbf9; sha256 625a5202e5a59e39e1dcd7a70c74d989b4d2ec174f2357cff5fce7b93dbafef4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125014. Agents can read the archived copy with the MCP tool read_document.